356 related articles for article (PubMed ID: 10772653)
1. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.
Montero A; Okada Y; Tomita M; Ito M; Tsurukami H; Nakamura T; Doetschman T; Coffin JD; Hurley MM
J Clin Invest; 2000 Apr; 105(8):1085-93. PubMed ID: 10772653
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice.
Naganawa T; Xiao L; Coffin JD; Doetschman T; Sabbieti MG; Agas D; Hurley MM
J Cell Biochem; 2008 Apr; 103(6):1975-88. PubMed ID: 17955502
[TBL] [Abstract][Full Text] [Related]
3. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
Okada Y; Montero A; Zhang X; Sobue T; Lorenzo J; Doetschman T; Coffin JD; Hurley MM
J Biol Chem; 2003 Jun; 278(23):21258-66. PubMed ID: 12665515
[TBL] [Abstract][Full Text] [Related]
4. Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis.
Homer-Bouthiette C; Doetschman T; Xiao L; Hurley MM
J Biol Chem; 2014 Dec; 289(52):36303-14. PubMed ID: 25389287
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.
Xiao L; Sobue T; Esliger A; Kronenberg MS; Coffin JD; Doetschman T; Hurley MM
Bone; 2010 Aug; 47(2):360-70. PubMed ID: 20510392
[TBL] [Abstract][Full Text] [Related]
6. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8.
Valta MP; Hentunen T; Qu Q; Valve EM; Harjula A; Seppänen JA; Väänänen HK; Härkönen PL
Endocrinology; 2006 May; 147(5):2171-82. PubMed ID: 16439448
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells.
Li CF; Hughes-Fulford M
J Bone Miner Res; 2006 Jun; 21(6):946-55. PubMed ID: 16753025
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice.
Naganawa T; Xiao L; Abogunde E; Sobue T; Kalajzic I; Sabbieti M; Agas D; Hurley MM
Biochem Biophys Res Commun; 2006 Jan; 339(2):490-8. PubMed ID: 16298332
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 2 positively regulates expression of activating transcription factor 4 in osteoblasts.
Fei Y; Xiao L; Hurley MM
Biochem Biophys Res Commun; 2010 Jan; 391(1):335-9. PubMed ID: 19913500
[TBL] [Abstract][Full Text] [Related]
10. Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice.
Xiao L; Liu P; Li X; Doetschman T; Coffin JD; Drissi H; Hurley MM
J Biol Chem; 2009 Jan; 284(5):3170-3182. PubMed ID: 19056741
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
[TBL] [Abstract][Full Text] [Related]
12. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
Hirasawa H; Tanaka S; Sakai A; Tsutsui M; Shimokawa H; Miyata H; Moriwaki S; Niida S; Ito M; Nakamura T
J Bone Miner Res; 2007 Jul; 22(7):1020-30. PubMed ID: 17388726
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.
Fei Y; Xiao L; Doetschman T; Coffin DJ; Hurley MM
J Biol Chem; 2011 Nov; 286(47):40575-83. PubMed ID: 21987573
[TBL] [Abstract][Full Text] [Related]
14. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
15. Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential.
Otomo H; Sakai A; Uchida S; Tanaka S; Watanuki M; Moriwaki S; Niida S; Nakamura T
Bone; 2007 Jun; 40(6):1494-501. PubMed ID: 17379594
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L; Du E; Homer-Bouthiette C; Hurley MM
Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
[TBL] [Abstract][Full Text] [Related]
17. The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression.
Fei Y; Xiao L; Hurley MM
Biochem Biophys Res Commun; 2011 Aug; 412(1):160-4. PubMed ID: 21806973
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells.
Jiang T; Ge S; Shim YH; Zhang C; Cao D
Int J Clin Exp Pathol; 2015; 8(3):2946-54. PubMed ID: 26045803
[TBL] [Abstract][Full Text] [Related]
19. Effects of BMP-2 on osteoblastic cells and on skeletal growth and bone formation in unloaded rats.
Zerath E; Holy X; Noël B; Malouvier A; Hott M; Marie PJ
Growth Horm IGF Res; 1998 Apr; 8(2):141-9. PubMed ID: 10987681
[TBL] [Abstract][Full Text] [Related]
20. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells.
Ling L; Murali S; Dombrowski C; Haupt LM; Stein GS; van Wijnen AJ; Nurcombe V; Cool SM
J Cell Physiol; 2006 Dec; 209(3):811-25. PubMed ID: 16972247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
